BioGaia AB (publ) (ADR)
General ticker "BIOGY" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $1.2B (TTM average)
BioGaia AB (publ) (ADR) follows the US Stock Market performance with the rate: 44.9%.
Estimated limits based on current volatility of 0.0%: low 12.45$, high 12.45$
Factors to consider:
- Company pays dividends (annually): last record date 2026-05-11, amount 0.42$ (Y3.37%)
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [8.49$, 13.38$]
- 2026-12-31 to 2027-12-31 estimated range: [9.00$, 14.05$]
Financial Metrics affecting the BIOGY estimates:
- Positive: with PPE of 3.3 at the end of fiscal year the price was neutral
- Positive: 22.71 < Operating profit margin, % of 26.82
- Positive: Return on assets ratio (scaled to [-100,100]) of 17.24 > 10.47
- Positive: 1.94 < Operating cash flow per share per price, % of 3.01
- Negative: Shareholder equity ratio, % of 82.25 > 81.82
- Positive: -0.07 < Investing cash flow per share per price, % of -0.03
- Positive: Industry inventory ratio change (median), % of 0.97 <= 1.05
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: 0.02 < Interest expense per share per price, % of 0.08
Short-term BIOGY quotes
Long-term BIOGY plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | SEK1,296.51MM | SEK1,422.72MM | SEK1,538.17MM |
| Operating Expenses | SEK853.40MM | SEK999.35MM | SEK1,125.70MM |
| Operating Income | SEK443.10MM | SEK423.37MM | SEK412.47MM |
| Non-Operating Income | SEK25.73MM | SEK24.45MM | SEK8.75MM |
| Interest Expense | SEK0.81MM | SEK14.92MM | SEK8.45MM |
| R&D Expense | SEK106.78MM | SEK157.10MM | SEK115.72MM |
| Income(Loss) | SEK468.83MM | SEK447.82MM | SEK421.22MM |
| Taxes | SEK103.48MM | SEK96.43MM | SEK88.45MM |
| Net Income(Loss)* | SEK287.60MM | SEK279.40MM | SEK332.76MM |
| Stockholders Equity | SEK2,030.34MM | SEK1,723.93MM | SEK1,314.22MM |
| Inventory | SEK181.20MM | SEK0.00MM | SEK0.00MM |
| Assets | SEK2,333.19MM | SEK2,034.01MM | SEK1,597.81MM |
| Operating Cash Flow | SEK425.96MM | SEK373.22MM | SEK306.57MM |
| Capital expenditure | SEK48.71MM | SEK14.15MM | SEK3.60MM |
| Investing Cash Flow | SEK-50.94MM | SEK-14.07MM | SEK-3.34MM |
| Financing Cash Flow | SEK-308.42MM | SEK-689.72MM | SEK-709.87MM |
| Earnings Per Share** | SEK2.85 | SEK2.76 | SEK3.29 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.